Phase 2 COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to understand the study and are willing to sign a written consent form
- People aged between 14 and 65 years
- People who have been diagnosed with a specific form of chronic graft-versus-host disease (a condition that can occur after a stem cell or bone marrow transplant) that causes skin hardening, tightening of tissue beneath the skin, or limited joint movement, diagnosed using established 2014 guidelines
- People who have previously been treated with steroid medicines for at least 12 months plus at least one other systemic (whole-body) treatment, OR who have received steroid medicines along with at least two other systemic treatments
- People whose general physical functioning meets a minimum level as measured by a standard medical scoring tool (confirm with trial site)
- People whose blood test results show a sufficient level of infection-fighting white blood cells (neutrophils above 1,000 per microlitre)
- People whose blood test results show a sufficient level of platelets (at least 50,000 per microlitre)
Who may not be able to join:
- People whose liver function blood test results show bilirubin levels more than 1.5 times the accepted upper normal limit
- People whose kidneys are not filtering blood well enough, based on a standard kidney function measurement (confirm with trial site)
- People who have an infection that is not currently under control
- People who have heart or lung disease that is not currently under control
- People with any other health condition that the trial doctor considers would make participation in the study unsuitable
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 027-85726003
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Skin and/or Joint/Fascia NIH cGVHD Scores
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.